As with PET/CT using other PSMA-targeted radiotracers [10,11,12], the detection rate with gallium-68 (68Ga)-PSMA-11 PET/CT of lesions suspicious for prostate cancer is well known to rise along with PSA concentration [13,14]. This evidence concerns the gene FOLH1 and prostate carcinoma.